Skip to main content
. Author manuscript; available in PMC: 2018 Jun 9.
Published in final edited form as: Acta Derm Venereol. 2017 Jun 9;97(6):761–762. doi: 10.2340/00015555-2645

Fig. 1. Patients before and after treatment.

Fig. 1

(a) Significant glabellar furrows at presentation in patient 1. (b) 4 weeks after treatment with BTX-A. (c) Significantly thickened skin on the eyelids and forehead with furrowing at presentation in patient 2. (d) 1 week after treatment with BTX-A, showing exacerbation of the eyelid ptosis that caused opening the eyes. (e) Facial enlargement with deep folds in the skin of the forehead and glabellar region and acne vulgaris on the forehead in patient 3. (f) 4, weeks after treatment with BTX-A.